期刊
DIGESTION
卷 86, 期 -, 页码 45-54出版社
KARGER
DOI: 10.1159/000341941
关键词
Pregnancy; Breastfeeding; Medical therapy benefits
资金
- Swiss National Science Foundation [320000-114009/3, 32473B_135694/1]
- Zurich Center for Integrative Human Physiology of the University of Zurich
- Swiss IBD Cohort [3347CO-108792]
- Swiss National Science Foundation (SNF) [32473B_135694] Funding Source: Swiss National Science Foundation (SNF)
Inflammatory bowel disease (IBD) is frequent in women during their peak reproductive years. Accordingly, a significant number of questions and uncertainties arise from this population regarding the risk of transmission of IBD to the offspring, the impact of the disease and therapies on the fertility, the role of the disease on the course of the pregnancy and the mode of delivery, the impact of the therapy on the pregnancy and fetal development as well as breastfeeding. The safety of medical therapy during pregnancy and lactation is a major concern for both pregnant women and their partners as well as for physicians. As a general rule, it can be stated that the benefit of continuing medical therapy in IBD during pregnancy outweighs the potential risks in the vast majority of instances. This article will review recent developments on this topic consistent with the European Crohn's and Colitis Organization guidelines. Copyright (C) 2012 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据